A 50-year-old man undergoes total thyroidectomy for papillary thyroid carcinoma (PTC). Histopathology confirms PTC with vascular invasion and extrathyroidal extension. Six weeks post-operatively, serum thyroglobulin (Tg) is elevated at 8 ng/mL (normal <0.5 ng/mL) despite TSH suppression. Which is the most appropriate next investigation to detect metastatic disease?

Explanation

## Investigation of Choice for Metastatic PTC Detection **Key Point:** Radioiodine whole-body scan (I-131 WBS) is the gold standard investigation for detecting metastatic papillary thyroid carcinoma when serum thyroglobulin is elevated post-thyroidectomy. ### Thyroglobulin as a Tumor Marker in PTC 1. **Highly sensitive and specific** — Tg is produced only by thyroid follicular cells; elevated Tg post-thyroidectomy indicates residual or metastatic thyroid tissue. 2. **Prognostic significance** — Tg >1 ng/mL on TSH suppression or >2 ng/mL on TSH stimulation suggests metastatic disease in >90% of cases. 3. **TSH stimulation enhances sensitivity** — Tg is TSH-dependent; stimulation via hormone withdrawal or rhTSH increases Tg secretion, improving detection of small metastases. ### Why I-131 WBS is the Investigation of Choice | Feature | I-131 WBS | Ultrasound | Chest X-ray | Anti-Tg | |---|---|---|---|---| | **Detects iodine-avid metastases** | Yes (gold standard) | No | No | No | | **Whole-body coverage** | Yes | Neck only | Chest only | N/A | | **Sensitivity for metastases** | 80–90% | 50–70% | 30–40% | N/A | | **Therapeutic potential** | Yes (I-131 ablation) | No | No | No | | **Functional information** | Yes (iodine uptake) | Anatomic only | Anatomic only | Antibody interference | **Clinical Pearl:** I-131 WBS should be performed after TSH stimulation (either by thyroid hormone withdrawal for 4–6 weeks or rhTSH injection) to maximize sensitivity. rhTSH is preferred in clinical practice because it avoids hypothyroid symptoms and is faster. **High-Yield:** Elevated Tg with negative I-131 WBS suggests non-iodine-avid metastases; in such cases, FDG-PET/CT becomes the next investigation of choice. **Mnemonic:** **STIR** — Stimulate TSH, I-131 scan, Residual/metastatic disease detection, Radioiodine therapy. ### Why Other Investigations Are Not First-Line 1. **Serum thyroglobulin antibodies (anti-Tg)** — Measured to detect antibody interference with Tg assay (false-negative Tg in ~5–10% of patients). Does not detect metastases; only explains discordant Tg results. 2. **Ultrasound of the neck** — Useful for detecting neck lymph node metastases but provides limited whole-body assessment. Should be performed but is complementary to I-131 WBS, not a substitute. 3. **Chest X-ray and abdominal ultrasound** — Low sensitivity for small metastases. Useful for detecting large pulmonary or hepatic lesions but miss micrometastases detected by I-131 WBS. ### Algorithm for Elevated Tg Post-Thyroidectomy ```mermaid flowchart TD A[PTC post-thyroidectomy]:::outcome --> B[Serum Tg elevated]:::outcome B --> C[Check anti-Tg antibodies]:::action C --> D{Anti-Tg positive?}:::decision D -->|Yes| E[Antibody interference likely<br/>Repeat Tg assay or use<br/>alternative method]:::action D -->|No| F[Proceed to I-131 WBS<br/>after TSH stimulation]:::action F --> G{I-131 WBS positive?}:::decision G -->|Yes| H[Iodine-avid metastases<br/>I-131 therapy]:::action G -->|No| I[Non-iodine-avid metastases<br/>FDG-PET/CT]:::action ``` [cite:Robbins 10e Ch 24]